AbCellera Biologics Inc. (NASDAQ: ABCL)

$4.15 +0.33 (+8.64%)
As of Apr 30, 2026 03:59 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001703057
Add ratio to table...

About

AbCellera Biologics Inc. specializes in the discovery and development of antibody-based therapies, leveraging advanced technologies to identify and optimize therapeutic antibodies for a range of diseases. The company operates within the biotechnology sector, focusing on the creation of innovative biological drugs designed to address unmet medical needs. Its core expertise lies in utilizing high-throughput screening and single-cell technologies to develop antibodies that can target specific disease pathways, offering potential treatments for conditions...

Read more

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 109.90 Bn 27.78 9.16 -
2 REGN Regeneron Pharmaceuticals, Inc. 76.53 Bn 16.96 5.34 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 39.60 Bn 143.93 12.57 -
4 RVMD Revolution Medicines, Inc. 27.52 Bn -24.37 33,158.07 -
5 ZLAB Zai Lab Ltd 24.25 Bn -138.37 100.02 0.20 Bn
6 MESO Mesoblast Ltd 22.87 Bn -179.20 1,330.04 0.12 Bn
7 RPRX Royalty Pharma plc 21.29 Bn 27.68 8.95 8.95 Bn
8 ROIV Roivant Sciences Ltd. 19.34 Bn -31.53 3,368.96 -